InvestSMART

Imricor Medical Systems Inc (ASX: IMR) - Announcements

Current share price for IMR : $1.505 0.055 (3.53%)+

ASX company news and announcements for Imricor Medical Systems Inc (IMR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Imricor Medical Systems Inc (IMR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Imricor Medical Systems Inc (IMR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Imricor Medical Systems Inc (IMR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$540 FY22 Results Webinar 8 Feb 2023 9:56AM $0.190 $1.505 risen by 692.11%
$540 Change in substantial holding 7 Feb 2023 8:19AM $0.190 $1.505 risen by 692.11%
$540 Change in substantial holding 3 Feb 2023 8:21AM $0.220 $1.505 risen by 584.09%
$540 Imricor and GE HealthCare MOU for Collaboration 27 Jan 2023 8:51AM $0.270 $1.505 risen by 457.41%
$540 Imricor Receives IDE Approval from US FDA 24 Jan 2023 9:21AM $0.270 $1.505 risen by 457.41%
$540 Imricor Q4 FY22 Quarterley Activities Report and Appendix 4C 20 Jan 2023 9:27AM $0.305 $1.505 risen by 393.44%
$540 Notification of cessation of securities - IMR 13 Jan 2023 12:46PM $0.345 $1.505 risen by 336.23%
$540 Notification regarding unquoted securities - IMR 3 Jan 2023 9:21AM $0.365 $1.505 risen by 312.33%
$540 Cleansing Notice - Convertible Note Tranche 1 23 Dec 2022 11:30AM $0.375 $1.505 risen by 301.33%
$540 Appendix 3B - Tranche 1 Convertible Note and Warrants 22 Dec 2022 5:12PM $0.375 $1.505 risen by 301.33%
$540 Imricor Recives North Dakota US$1.5m LIFT Loan Approval 22 Dec 2022 9:35AM $0.380 $1.505 risen by 296.05%
$540 Notification of cessation of securities - IMR 21 Dec 2022 9:36AM $0.360 $1.505 risen by 318.06%
$540 Imricor to Raise US$5 million via Convertible Note 19 Dec 2022 9:37AM $0.400 $1.505 risen by 276.25%
$540 VISABL-VT Ethics Committee Approval and NorthStar-MR Update 15 Dec 2022 9:07AM $0.385 $1.505 risen by 290.91%
$540 US$5 Million Convertible Note and Business Update 12 Dec 2022 10:02AM $0.385 $1.505 risen by 290.91%
$540 Appendix 3Y - SW 18 Nov 2022 10:07AM $0.330 $1.505 risen by 356.06%
$540 Virtual Open House and Business Overview Session 15 Nov 2022 8:57AM $0.370 $1.505 risen by 306.76%
$540 Appendix 3Y - SW 11 Nov 2022 9:43AM $0.370 $1.505 risen by 306.76%
$540 Investor Presentation 27 Oct 2022 8:27AM $0.260 $1.505 risen by 478.85%
$540 Imricor Q3 FY22 Quarterley Activities Report and Appendix 4C 27 Oct 2022 8:26AM $0.260 $1.505 risen by 478.85%
$540 U.S. Restriction On CHESS Depository Interests Removed 25 Oct 2022 8:55AM $0.260 $1.505 risen by 478.85%
$540 Details of Q3 Appendix 4C Investor Webinar 24 Oct 2022 8:19AM $0.265 $1.505 risen by 467.92%
$540 Notification of cessation of securities - IMR 11 Oct 2022 10:54AM $0.300 $1.505 risen by 401.67%
$540 Notification regarding unquoted securities - IMR 11 Oct 2022 8:19AM $0.300 $1.505 risen by 401.67%
$540 Imricor submits application to commence VT trail in Europe 19 Sep 2022 11:48AM $0.320 $1.505 risen by 370.31%

326 - 350 of 602 results

Page 14 of 25

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.